Selecting a CRO

A signed CRO contract is not an operating model. 

In 25+ years across CRO leadership and helping sponsor operations, I kept seeing the same pattern:  brilliant science, a committed team, a carefully chosen CRO…and momentum quietly leaking away because no one had built the operating system around the partnership.

It's never a lack of effort or intelligence.  Emerging sponsors are running lean, moving fast, and answering to a board that wants first patient in yesterday.  Structure feels like a luxury.  So the relationship starts without clear decision rights, without agreed measures of performance, without a path for raising problems early, and by the time something surfaces, it's a timeline problem instead of a conversation.

I believe a CRO can be a genuine extension of your team, but it cannot be a substitute for sponsor accountability.  Your program, your decisions, your data, your risk.  Operational excellence is not bureaucracy; it's what lets great science reach patients without preventable execution failures.

I work with emerging biotech and biopharma sponsors — usually when a team is ready to select a CRO.  Three ways I plug in:

📍CRO selection — turning development strategy into real evaluation criteria, a disciplined RFP, and a defensible decision.

📍Governance and oversight retainer — the metrics, escalation path, meeting rhythm, and risk visibility that keep a partnership honest in both directions.

📍End-to-end support — building the clinical operations foundation from development planning through start-up and delivery excellence.

My job is not to sit between a biotech and its CRO.  It's to help the sponsor lead the relationship with enough clarity and confidence that both organizations do their very best work and have a strong, sustainable partnership that can move forward through the .

If you're building your first — or next — clinical program and want a sponsor-side partner in the room, I would love to talk with you about my CRO selection and governance approach.

The signature is the start of the work, not the end of it. ABRA helps sponsors with building the operating model around the contract.

Previous
Previous

Financial Fluency for Clinical Research Leaders

Next
Next

Transitioning a Study From One CRO to Another